BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19343734)

  • 1. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.
    Ananias HJ; van den Heuvel MC; Helfrich W; de Jong IJ
    Prostate; 2009 Jul; 69(10):1101-8. PubMed ID: 19343734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
    Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE
    Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases.
    Sweat SD; Pacelli A; Murphy GP; Bostwick DG
    Urology; 1998 Oct; 52(4):637-40. PubMed ID: 9763084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction.
    Kusuda Y; Miyake H; Kurahashi T; Fujisawa M
    Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy.
    Rybalov M; Ananias HJ; Hoving HD; van der Poel HG; Rosati S; de Jong IJ
    Int J Mol Sci; 2014 Apr; 15(4):6046-61. PubMed ID: 24727373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z; Wenlv S
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer.
    Ross JS; Sheehan CE; Fisher HA; Kaufman RP; Kaur P; Gray K; Webb I; Gray GS; Mosher R; Kallakury BV
    Clin Cancer Res; 2003 Dec; 9(17):6357-62. PubMed ID: 14695135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer.
    Eder M; Schäfer M; Bauder-Wüst U; Haberkorn U; Eisenhut M; Kopka K
    Prostate; 2014 May; 74(6):659-68. PubMed ID: 24464532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma.
    Chang SS; Reuter VE; Heston WD; Gaudin PB
    Urology; 2001 Jun; 57(6):1179-83. PubMed ID: 11377343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
    Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
    Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice.
    Yang D; Holt GE; Velders MP; Kwon ED; Kast WM
    Cancer Res; 2001 Aug; 61(15):5857-60. PubMed ID: 11479226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.
    Gu Z; Thomas G; Yamashiro J; Shintaku IP; Dorey F; Raitano A; Witte ON; Said JW; Loda M; Reiter RE
    Oncogene; 2000 Mar; 19(10):1288-96. PubMed ID: 10713670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific membrane antigen expression in normal and malignant human tissues.
    Silver DA; Pellicer I; Fair WR; Heston WD; Cordon-Cardo C
    Clin Cancer Res; 1997 Jan; 3(1):81-5. PubMed ID: 9815541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target.
    Moore M; Panjwani S; Mathew R; Crowley M; Liu YF; Aronova A; Finnerty B; Zarnegar R; Fahey TJ; Scognamiglio T
    Endocr Pathol; 2017 Dec; 28(4):339-344. PubMed ID: 28844117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bispecific radioligands targeting prostate-specific membrane antigen and gastrin-releasing peptide receptors on the surface of prostate cancer cells.
    Liolios C; Sachpekidis C; Schäfer M; Kopka K
    J Labelled Comp Radiopharm; 2019 Jun; 62(8):510-522. PubMed ID: 31070273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
    Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
    Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of prostate stem cell antigen (PSCA) in prostate cancer: a tissue microarray study of Iranian patients.
    Taeb J; Asgari M; Abolhasani M; Farajollahi MM; Madjd Z
    Pathol Res Pract; 2014 Jan; 210(1):18-23. PubMed ID: 24183365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes and high malignant grade.
    Schmidt B; Anastasiadis AG; Seifert HH; Franke KH; Oya M; Ackermann R
    Anticancer Res; 2003; 23(5A):3991-9. PubMed ID: 14666708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.
    Kasoha M; Unger C; Solomayer EF; Bohle RM; Zaharia C; Khreich F; Wagenpfeil S; Juhasz-Böss I
    Clin Exp Metastasis; 2017 Dec; 34(8):479-490. PubMed ID: 29426963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system.
    Arndt C; Feldmann A; Koristka S; Cartellieri M; Dimmel M; Ehninger A; Ehninger G; Bachmann M
    Prostate; 2014 Sep; 74(13):1335-46. PubMed ID: 25053443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.